RYBELSUS

This brand name is authorized in Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug RYBELSUS contains one active pharmaceutical ingredient (API):

1 Semaglutide UNII 53AXN4NNHX - SEMAGLUTIDE

Semaglutide is a GLP-1 receptor agonist. It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food. This helps with the control of blood glucose levels. Read about Semaglutide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RYBELSUS Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BJ06		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526620120008707, 526620120008807, 526620120008907, 526620120009007, 526620120009107, 526620120009207, 526620120009307, 526620120009407, 526620120009507, 526620120009607, 526620120009707, 526620120009807
Country: CA	Health Products and Food Branch	Identifier(s): 02497581, 02497603, 02497611
Country: EE	Ravimiamet	Identifier(s): 1815814, 1815825, 1815836, 1815847, 1815869, 1815870, 1815881, 1815892, 1815904, 1815915
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1201430002, 1201430005, 1201430008
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 047094, 146870, 383205, 439552, 478961
Country: FR	Base de données publique des médicaments	Identifier(s): 64596449, 66639842, 67593141
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 387319, 387322, 387325
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8786, 8787, 8788
Country: IT	Agenzia del Farmaco	Identifier(s): 048719013, 048719025, 048719037, 048719049, 048719052, 048719064, 048719076, 048719088, 048719090, 048719102, 048719114, 048719126, 048719138, 048719140, 048719153
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499014F1021, 2499014F2028, 2499014F3024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1089852, 1089853, 1089854, 1089855, 1089856, 1089857, 1089858, 1089859, 1089860, 1089861, 1091558, 1091559, 1091560
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 203394, 203408, 203416
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100434043, 100434050, 100434066
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66741001, W66741002, W66741003, W66741004, W66742002, W66742003, W66742004, W66743001, W66743002, W66743003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699676011230, 8699676011247, 8699676011254, 8699676011261, 8699676011278, 8699676011285, 8699676011292, 8699676011308, 8699676011315
Country: US	FDA, National Drug Code	Identifier(s): 0169-4303, 0169-4307, 0169-4314